Seroepidemiology and Risk Factors of Hepatitis B Virus Infection: A Population-Based Azar Cohort Study

Overview

Journal Iran J Public Health

Date 2021 Mar 12

PMID 33708736

Citations 1

Authors

Ali Asghar Pouri

Morteza Ghojazadeh

Masoud Shirmohammadi

Amir-Taher Eftekhar-Sadat

Mohammad Hossein Somi

Affiliations

Soon will be listed here.

Abstract

Background: Hepatitis B is a major global health problem. It can cause chronic infections and put people at high risk of death from cirrhosis and hepatocellular carcinoma. The aim of this study was to report the epidemiological features of hepatitis B virus (HBV) infection and risk factors based on the data from Azar Cohort.

Methods: The population of this study comprised the people in the age range of 35-70 yr from Azar cohort, East Azerbaijan Province, Iran between 2015 and 2016. Based on cluster sampling, 4,949 people were selected and invited to complete the questionnaire and perform the tests. Blood samples were analyzed for serum HBV markers (HBsAg, HBsAb and HBcAb) by ELFA method. The data were analyzed using SPSS statistical software.

Results: The mean (SD) age of the participants was 49.15 ± 9.02 years. The frequency rates of HBsAg, HBsAb and HBcAb were estimated as 1.03%, 16.9% and 24.95%, respectively. There was statistically significant association between family history of hepatitis (<0.001) and jaundice history (<0.001) with the presence of HBsAg. There was also a positive correlation between marital status (=0.002), history of hospitalization (<0.001), smoking (=0.001), dental procedures (<0.001), foreign travels (=0.005), occupation status (=0.002) and the presence of HBcAb.

Conclusion: The frequency of hepatitis B in Azar Cohort was 1.03% which is a lower rate compared with other reports from Iran. The association of the population studied and the increase of public awareness in this area can probably prevent this disease.

Citing Articles

Hepatitis B virus infection status and associated factors among health care workers in selected hospitals in Kisumu County, Kenya: A cross-sectional study.

Mboya F, Daud I, Ondondo R, Onguru D PLOS Glob Public Health. 2023; 3(9):e0001535.

PMID: 37729120 PMC: 10511138. DOI: 10.1371/journal.pgph.0001535.

References

Kim W . Epidemiology of hepatitis B in the United States. Hepatology. 2009; 49(5 Suppl):S28-34. PMC: 3290915. DOI: 10.1002/hep.22975. View

Salehi M, Alavian S, Tabatabaei S, Izadi S, Moghaddam E, Amini Kafi-Abad S . Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5):283-8. PMC: 3398635. View

Alavian S, Fallahian F, Bagheri Lankarani K . Implementing strategies for hepatitis B vaccination. Saudi J Kidney Dis Transpl. 2010; 21(1):10-22. View

Keyvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, Saeedian F . A population based study on hepatitis B virus in northern iran, amol. Hepat Mon. 2014; 14(8):e20540. PMC: 4165985. DOI: 10.5812/hepatmon.20540. View

Moezzi M, Imani R, Khosravi N, Pourheidar B, Ganji F, Karimi A . Hepatitis B seroprevalence and risk factors in adult population of chaharmahal and bakhtiari province in 2013. Hepat Mon. 2014; 14(5):e17398. PMC: 4030265. DOI: 10.5812/hepatmon.17389. View

Ott J, Stevens G, Groeger J, Wiersma S . Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12):2212-9. DOI: 10.1016/j.vaccine.2011.12.116. View

Ghadir M, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H . Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012; 12(2):112-7. PMC: 3321318. DOI: 10.5812/hepatmon.822. View

Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H . The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3):225-31. View

Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei M, Saburi A, Fereidouni M . Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016; 16(9):e36452. PMC: 5090805. DOI: 10.5812/hepatmon.36452. View

10.

Ansari-Moghaddam A, Ostovaneh M, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H . Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon. 2012; 12(9):e6618. PMC: 3475139. DOI: 10.5812/hepatmon.6618. View

11.

Song L, Xuan N, Toan N, Binh V, Boldt A, Kremsner P . Association of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infection. Eur Cytokine Netw. 2008; 19(4):204-10. DOI: 10.1684/ecn.2008.0137. View

12.

Behzad-Behbahani A, Mafi-Nejad A, Tabei S, Lankarani K, Torab A, Moaddeb A . Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res. 2006; 123(1):37-42. View

13.

Lok A, McMahon B . Chronic hepatitis B: update 2009. Hepatology. 2009; 50(3):661-2. DOI: 10.1002/hep.23190. View

14.

Van Damme P, Moiseeva A, Marichev I, Kervyn A, Booy R, Kuriyakose S . Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study. BMC Infect Dis. 2010; 10:357. PMC: 3016379. DOI: 10.1186/1471-2334-10-357. View

15.

Alter M, Margolis H . The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am. 1990; 74(6):1529-41. DOI: 10.1016/s0025-7125(16)30493-x. View

16.

Weinbaum C, Williams I, Mast E, Wang S, Finelli L, Wasley A . Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008; 57(RR-8):1-20. View

17.

Wright T . Introduction to chronic hepatitis B infection. Am J Gastroenterol. 2006; 101 Suppl 1:S1-6. DOI: 10.1111/j.1572-0241.2006.00469.x. View

18.

Zali M, Mohammad K, Noorbala A, Noorimayer B, Shahraz S, Sahraz S . Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2006; 11(1-2):62-7. View

19.

Shakeri M, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia M, Rostami S . The prevalence of hepatitis B virus infection in mashhad, iran: a population-based study. Iran Red Crescent Med J. 2013; 15(3):245-8. PMC: 3745755. DOI: 10.5812/ircmj.8200. View

20.

Zhang H, Yin J, Li Y, Li C, Ren H, Gu C . Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut. 2008; 57(12):1713-20. PMC: 2582333. DOI: 10.1136/gut.2008.157149. View